Utility of intra-abdominal pressure and clinical ultrasound for guiding diuretic treatment in patients with acute heart failure

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512901-22-00

Acronym

PI23/00797

Enrollment

168

Registered

2024-08-01

Start date

2025-02-10

Completion date

Unknown

Last updated

2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Heart Failure

Brief summary

Congestion absence after the first 72h of intravenous diuretic treatment in hospitalization as determined by the ADVOR scale.

Interventions

DRUGFUROSEMIDE

DRUGHYDROCHLOROTHIAZIDE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Congestion absence after the first 72h of intravenous diuretic treatment in hospitalization as determined by the ADVOR scale.	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026